Clinical Trials Logo

Filter by:
NCT ID: NCT04677387 Completed - Naloxone Clinical Trials

Nalox-Comm: Naloxone Communication Training for Pharmacists

Nalox-Comm
Start date: July 1, 2021
Phase: N/A
Study type: Interventional

This is a pilot Randomized Controlled Trial (RCT) in which 120 pharmacists will be randomized to an experimental or control group and data on naloxone dispensing and secondary outcomes will be collected over the course of the RCT.

NCT ID: NCT04676737 Completed - Clinical trials for Fuchs' Endothelial Dystrophy

TTHX1114(NM141) in Combination With DWEK/DSO

Start date: February 1, 2021
Phase: Phase 2
Study type: Interventional

Open label, single-treatment, with a concurrent non-treatment control

NCT ID: NCT04676724 Completed - Hepatitis B Clinical Trials

Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)

B-Together
Start date: January 28, 2021
Phase: Phase 2
Study type: Interventional

This study is intended to evaluate if 12 or 24 weeks of treatment with GSK3228836 followed by up to 24 weeks of pegylated interferon (PegIFN) can increase the rate of hepatitis B virus surface antigen (HBsAg) loss in participants on stable nucleos(t)ide analogue (NA) therapy, and whether virologic response can be sustained once PegIFN treatment is discontinued. Participants will be randomized to receive GSK3228836 for 12 or 24 weeks followed by up to 24 weeks of PegIFN.

NCT ID: NCT04676698 Completed - Job Related Stress Clinical Trials

Three Good Things 2020: a Brief Text-based Wellness Intervention

Start date: February 3, 2021
Phase: N/A
Study type: Interventional

This trial will be open to all Michigan Medicine Department of Family Medicine faculty, resident, or staff. The intervention will consist of asking participants the "3 Good Things" based on positive psychology theory. Participants will be asked to list three things that went well that day and to consider their role in these outcomes. Pre and post surveys will be completed to evaluate this intervention. At the end of the trial the study team will also select a limited number of entries from participants to share some of the "good things" which people listed. These will be edited to ensure writer anonymity and participants will be informed of this plan in the study introduction.

NCT ID: NCT04676685 Completed - Healthy Volunteers Clinical Trials

A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants

Start date: December 16, 2020
Phase: Phase 1
Study type: Interventional

The primary purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of E2730 of multiple ascending oral doses in healthy adult participants and to assess the differences in PK, safety, and tolerability of E2730 between healthy Japanese and non-Japanese participants following multiple doses. This study will also determine the effect of food on PK of E2730.

NCT ID: NCT04676633 Completed - Clinical trials for Hepatocellular Carcinoma

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Start date: March 1, 2021
Phase: Phase 1
Study type: Interventional

This is an open label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of STP705 administered intratumorally in cholangiocarcinoma, hepatocellular carcinoma or liver metastasis in subjects with advanced/metastatic or surgically unresectable solid tumors who are refractory to standard therapy. Goals: 1. To determine the MTD or RP2D of STP705 when administered intratumorally into cholangiocarcinoma, hepatocellular carcinoma, or liver metastasis. 2. To establish the dose of STP705 recommended for future phase 2 studies when administered intratumorally.

NCT ID: NCT04676555 Completed - Clinical trials for Relapsing Forms of Multiple Sclerosis

Time and Motion Study for Ocrelizumab and Ofatumumab Administration in Relapsing Multiple Sclerosis

TIMIOS
Start date: May 11, 2021
Phase:
Study type: Observational

This is an observational cross-sectional study of Ocrelizumab or Ofatumumab administrations for Relapsing forms of Multiple Sclerosis (RMS) in selected sites in the US, the UK and Australia.

NCT ID: NCT04676542 Completed - Clinical trials for Cognitive Performance

The Effects of Externally Paced Exercise on Cognitive Performance and Stress in College Aged Students

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the acute effect of martial art exercise and aerobic exercise on cognitive performance in college age students. Cognitive performance is a term that encompasses our cognitive processes such as working memory, and executive functioning (decision making); research has found that externally paced (EP) exercise improves cognitive performance and executive functioning (EF). EP activities require decision making skills and higher-level executive functioning. Previous research studies have shown that acute as well as long term aerobic exercise improves cognitive performance Internally paced (IP) exercise requires less attention on task, which may result in less significant improvements in cognitive performance and executive function. However, there is limited research examining the effect that martial art exercise has on these higher-level cognitive functions.Theoretically, the martial art class will improve provide greater stimulation to the higher levels of the brain, causing a greater improvement in the executive function scores when compared to walking. This leads to the question, are externally paced aerobic activities more effective than an acute bout of aerobic exercise in improving executive function in college-aged adults? The investigators hypothesized that martial art training will have a greater impact on executive functioning than aerobic exercise in college-aged adults.

NCT ID: NCT04676490 Completed - Asthma in Children Clinical Trials

The RECORD-ED Pilot Study

Start date: December 15, 2020
Phase: N/A
Study type: Interventional

In this pilot randomized trial, the investigators will evaluate the feasibility, acceptability, and potential family-centered outcomes associated with providing asthma discharge instructions in audio-recorded format in addition to written format, compared to written instructions alone. The study will enroll 100 families of children being discharged home from an emergency department visit, who prefer either English or Spanish for medical care, and assess outcomes at 3 time-points.

NCT ID: NCT04676451 Completed - Cataract Clinical Trials

Femtosecond Laser Assisted Keratotomies for the Management of Corneal Astigmatism

Start date: May 14, 2018
Phase: N/A
Study type: Interventional

A cataract is a clouding of the lens that occurs naturally with age. Cataract surgery involves removal of the cloudy lens and replacement with an artificial one. A special laser (femtosecond laser) is now being used to help make cataract surgery safer and more accurate . The femtosecond laser can also be used to correct astigmatism, an irregular curvature of the cornea, at the time of cataract surgery through a procedure called astigmatic keratotomy (AK). This study is gathering information about the specific laser settings that are used to perform astigmatic keratotomies (AK) during cataract surgery. This information will be used to improve the outcomes of patients that receive cataract surgery with astigmatic keratotomies in the future.